MedTrace Logo

Intrapartum Glycemic Control in GDMA2

NCT05647798 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2

Last updated 2024-06-04

No results posted yet for this study

Summary

This is a randomized, parallel, controlled, non-inferiority trial to assess the impact of a tight versus a more liberalized intrapartum glycemic control in gestational diabetic mothers on neonatal glycemia. National guidelines for the management of intrapartum glucose in women with GDM are lacking. This is likely due to the scarcity of high-quality data on the topic.

Conditions

  • Pregnancy
  • Gestational Diabetes Mellitus, Class A2
  • Neonatal Hypoglycemia

Interventions

OTHER

Blood sugar check every 2 hours

Blood sugar check every 2 hours

OTHER

Blood sugar check every 4 hours

Blood sugar check every 4 hours

Sponsors & Collaborators

  • Inova Health Care Services

    lead OTHER

Principal Investigators

  • Jean W Thermolice, MD · Inova Healthcare Services

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-22
Primary Completion
2024-05-15
Completion
2024-05-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05647798 on ClinicalTrials.gov